319,188 Shares in The Clorox Company $CLX Acquired by Freestone Grove Partners LP

Posted by on Aug 28th, 2026

Freestone Grove Partners LP acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 319,188 shares of the company’s stock, valued at approximately $30,463,000. Freestone Grove Partners LP owned about 0.26% of Clorox as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Woodline Partners LP grew its stake in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the period. Baird Financial Group Inc. grew its stake in shares of Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after buying an additional 424 shares during the period. Jump Financial LLC increased its holdings in shares of Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia raised its position in shares of Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after buying an additional 3,352 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Down 0.6%

Shares of Clorox stock opened at $103.64 on Friday. The company’s fifty day moving average is $99.69 and its two-hundred day moving average is $102.72. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The company has a market capitalization of $12.53 billion, a P/E ratio of 21.50, a PEG ratio of 3.26 and a beta of 0.54. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company’s revenue was down 2.0% on a year-over-year basis. During the same period last year, the business posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Analysts forecast that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.8%. Clorox’s dividend payout ratio is currently 103.73%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CLX. Jefferies Financial Group cut Clorox from a “buy” rating to a “hold” rating and decreased their price objective for the company from $125.00 to $98.00 in a report on Tuesday, July 28th. Morgan Stanley cut their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. UBS Group increased their target price on shares of Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. BNP Paribas Exane lowered their price objective on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research report on Monday, July 20th. Finally, Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Twelve equities research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and an average target price of $102.40.

Get Our Latest Research Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.